Cognate BioServices is a contract development and manufacturing organization specializing in cell and gene-mediated cell therapy. The company has supported the development of FDA-approved therapies and conducted numerous studies in this field.

Cognate BioServices

Biotechnology Research

Charles River Laboratories

Cognate BioServices, a Charles River Company | 12,705 followers on LinkedIn. Your CDMO Partner from Concept to Commercial for Cell &amp; Gene Therapy Products | Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience we bring to the table. 
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advance cell therapy companies, organizations and institutions.

Charles Heslen

Quality Assurance Specialist at Cognate BioServices

Nicole Barham

Sr. QC Lab Tech at WMBarr & Companies

Monica Wilson

PD Scientist at CRL

Terri Jerbi

Cognate BioServices, a Charles River Company

msh id	COM:COGNATEBIOSERVICES
symbol	-
name	Cognate BioServices
homepage url	https://www.cognatebioservices.com
country	US
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	-
crunchbase url	https://www.crunchbase.com/organization/cognate-therapeutics
linkedin url	https://www.linkedin.com/company/cognate-bioservices
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COGN

COM:COGNATEBIOSERVICES

Cognate BioServices

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-